LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus.

    Yip, Ming Shum / Leung, Nancy Hiu Lan / Cheung, Chung Yan / Li, Ping Hung / Lee, Horace Hok Yeung / Daëron, Marc / Peiris, Joseph Sriyal Malik / Bruzzone, Roberto / Jaume, Martial

    Virology journal

    2014  Volume 11, Page(s) 82

    Abstract: ... and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome ... infection of human monocyte-derived macrophages by replication-competent SARS-CoV as well as Spike ... in human macrophages.: Methods: We have used primary human immune cells to evaluate their susceptibility ...

    Abstract Background: Public health risks associated to infection by human coronaviruses remain considerable and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome coronavirus (SARS-CoV). We have previously reported that antibodies elicited by a SARS-CoV vaccine candidate based on recombinant, full-length SARS-CoV Spike-protein trimers, trigger infection of immune cell lines. These observations prompted us to investigate the molecular mechanisms and responses to antibody-mediated infection in human macrophages.
    Methods: We have used primary human immune cells to evaluate their susceptibility to infection by SARS-CoV in the presence of anti-Spike antibodies. Fluorescence microscopy and real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) were utilized to assess occurrence and consequences of infection. To gain insight into the underlying molecular mechanism, we performed mutational analysis with a series of truncated and chimeric constructs of fragment crystallizable γ receptors (FcγR), which bind antibody-coated pathogens.
    Results: We show here that anti-Spike immune serum increased infection of human monocyte-derived macrophages by replication-competent SARS-CoV as well as Spike-pseudotyped lentiviral particles (SARS-CoVpp). Macrophages infected with SARS-CoV, however, did not support productive replication of the virus. Purified anti-viral IgGs, but not other soluble factor(s) from heat-inactivated mouse immune serum, were sufficient to enhance infection. Antibody-mediated infection was dependent on signaling-competent members of the human FcγRII family, which were shown to confer susceptibility to otherwise naïve ST486 cells, as binding of immune complexes to cell surface FcγRII was necessary but not sufficient to trigger antibody-dependent enhancement (ADE) of infection. Furthermore, only FcγRII with intact cytoplasmic signaling domains were competent to sustain ADE of SARS-CoVpp infection, thus providing additional information on the role of downstream signaling by FcγRII.
    Conclusions: These results demonstrate that human macrophages can be infected by SARS-CoV as a result of IgG-mediated ADE and indicate that this infection route requires signaling pathways activated downstream of binding to FcγRII receptors.
    MeSH term(s) Antibodies, Viral/immunology ; Cells, Cultured ; Endocytosis ; Humans ; Macrophages/virology ; Microscopy, Fluorescence ; Real-Time Polymerase Chain Reaction ; SARS Virus/physiology
    Chemical Substances Antibodies, Viral
    Keywords covid19
    Language English
    Publishing date 2014-05-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1743-422X
    ISSN (online) 1743-422X
    DOI 10.1186/1743-422X-11-82
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2.

    Mackin, Samantha R / Desai, Pritesh / Whitener, Bradley M / Karl, Courtney E / Liu, Meizi / Baric, Ralph S / Edwards, Darin K / Chicz, Taras M / McNamara, Ryan P / Alter, Galit / Diamond, Michael S

    Nature microbiology

    2023  Volume 8, Issue 4, Page(s) 569–580

    Abstract: Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with antigenic ... alveolar macrophages are required for vaccine-induced antibody-mediated protection against infection by antigenically ... clinical coronavirus disease 2019 outcome. However, a causal relationship between Fc effector functions and ...

    Abstract Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with antigenic changes in the spike protein are neutralized less efficiently by serum antibodies elicited by legacy vaccines against the ancestral Wuhan-1 virus. Nonetheless, these vaccines, including mRNA-1273 and BNT162b2, retained their ability to protect against severe disease and death, suggesting that other aspects of immunity control infection in the lung. Vaccine-elicited antibodies can bind Fc gamma receptors (FcγRs) and mediate effector functions against SARS-CoV-2 variants, and this property correlates with improved clinical coronavirus disease 2019 outcome. However, a causal relationship between Fc effector functions and vaccine-mediated protection against infection has not been established. Here, using passive and active immunization approaches in wild-type and FcγR-knockout mice, we determined the requirement for Fc effector functions to control SARS-CoV-2 infection. The antiviral activity of passively transferred immune serum was lost against multiple SARS-CoV-2 strains in mice lacking expression of activating FcγRs, especially murine FcγR III (CD16), or depleted of alveolar macrophages. After immunization with the pre-clinical mRNA-1273 vaccine, control of Omicron BA.5 infection in the respiratory tract also was lost in mice lacking FcγR III. Our passive and active immunization studies in mice suggest that Fc-FcγR engagement and alveolar macrophages are required for vaccine-induced antibody-mediated protection against infection by antigenically changed SARS-CoV-2 variants, including Omicron strains.
    MeSH term(s) Animals ; Humans ; Mice ; SARS-CoV-2/genetics ; 2019-nCoV Vaccine mRNA-1273 ; Receptors, IgG/genetics ; BNT162 Vaccine ; COVID-19/prevention & control ; Vaccines ; Antibodies, Viral ; Mice, Knockout
    Chemical Substances 2019-nCoV Vaccine mRNA-1273 (EPK39PL4R4) ; Receptors, IgG ; BNT162 Vaccine ; Vaccines ; Antibodies, Viral
    Language English
    Publishing date 2023-04-03
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2058-5276
    ISSN (online) 2058-5276
    DOI 10.1038/s41564-023-01359-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection.

    García-Nicolás, Obdulio / V'kovski, Philip / Zettl, Ferdinand / Zimmer, Gert / Thiel, Volker / Summerfield, Artur

    Frontiers in cellular and infection microbiology

    2021  Volume 11, Page(s) 644574

    Abstract: Vaccines are essential to control the spread of severe acute respiratory syndrome coronavirus-2 ... inflammatory cytokines in these cells, in sharp contrast to Middle East respiratory syndrome (MERS) coronavirus ... and the common cold human coronavirus 229E. Furthermore, serum from convalescent COVID-19 patients ...

    Abstract Vaccines are essential to control the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and to protect the vulnerable population. However, one safety concern of vaccination is the possible development of antibody-dependent enhancement (ADE) of SARS-CoV-2 infection. The potential infection of Fc receptor bearing cells such as macrophages, would support continued virus replication and inflammatory responses, and thereby potentially worsen the clinical outcome of COVID-19. Here we demonstrate that SARS-CoV-2 and SARS-CoV neither infect human monocyte-derived macrophages (hMDM) nor induce inflammatory cytokines in these cells, in sharp contrast to Middle East respiratory syndrome (MERS) coronavirus and the common cold human coronavirus 229E. Furthermore, serum from convalescent COVID-19 patients neither induced enhancement of SARS-CoV-2 infection nor innate immune response in hMDM. Although, hMDM expressed angiotensin-converting enzyme 2, no or very low levels of transmembrane protease serine 2 were found. These results support the view that ADE may not be involved in the immunopathological processes associated with COVID-19, however, more studies are necessary to understand the potential contribution of antibodies-virus complexes with other cells expressing FcR receptors.
    MeSH term(s) Antibodies, Viral ; COVID-19 ; Humans ; Macrophages ; Middle East Respiratory Syndrome Coronavirus ; SARS-CoV-2
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2021-04-12
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2021.644574
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.

    Ricke, Darrell O

    Frontiers in immunology

    2021  Volume 12, Page(s) 640093

    Abstract: ... to severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome coronavirus (MERS-CoV), and other coronavirus has been ... dysregulation, cytokine storms, acute respiratory distress syndrome (ARDS), etc. Development of vaccines ... Antibody-dependent enhancement (ADE) may be involved in the clinical observation of increased severity of symptoms associated ...

    Abstract COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease progression include lymphopenia, elevated proinflammatory cytokines and chemokines, accumulation of macrophages and neutrophils in lungs, immune dysregulation, cytokine storms, acute respiratory distress syndrome (ARDS), etc. Development of vaccines to severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome coronavirus (MERS-CoV), and other coronavirus has been difficult to create due to vaccine induced enhanced disease responses in animal models. Multiple betacoronaviruses including SARS-CoV-2 and SARS-CoV-1 expand cellular tropism by infecting some phagocytic cells (immature macrophages and dendritic cells) via antibody bound Fc receptor uptake of virus. Antibody-dependent enhancement (ADE) may be involved in the clinical observation of increased severity of symptoms associated with early high levels of SARS-CoV-2 antibodies in patients. Infants with multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 may also have ADE caused by maternally acquired SARS-CoV-2 antibodies bound to mast cells. ADE risks associated with SARS-CoV-2 has implications for COVID-19 and MIS-C treatments, B-cell vaccines, SARS-CoV-2 antibody therapy, and convalescent plasma therapy for patients. SARS-CoV-2 antibodies bound to mast cells may be involved in MIS-C and multisystem inflammatory syndrome in adults (MIS-A) following initial COVID-19 infection. SARS-CoV-2 antibodies bound to Fc receptors on macrophages and mast cells may represent two different mechanisms for ADE in patients. These two different ADE risks have possible implications for SARS-CoV-2 B-cell vaccines for subsets of populations based on age, cross-reactive antibodies, variabilities in antibody levels over time, and pregnancy. These models place increased emphasis on the importance of developing safe SARS-CoV-2 T cell vaccines that are not dependent upon antibodies.
    MeSH term(s) Animals ; Antibodies, Viral/metabolism ; Antibody-Dependent Enhancement ; COVID-19/immunology ; COVID-19/transmission ; Child ; Cross Reactions ; Female ; Humans ; Infant, Newborn ; Infectious Disease Transmission, Vertical ; Mast Cells/immunology ; Middle East Respiratory Syndrome Coronavirus/physiology ; Models, Immunological ; Phagocytes/immunology ; Pregnancy ; Receptors, Fc/metabolism ; Risk ; SARS-CoV-2/physiology ; Systemic Inflammatory Response Syndrome/immunology ; T-Lymphocytes/immunology
    Chemical Substances Antibodies, Viral ; Receptors, Fc
    Language English
    Publishing date 2021-02-24
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.640093
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages.

    Maemura, Tadashi / Kuroda, Makoto / Armbrust, Tammy / Yamayoshi, Seiya / Halfmann, Peter J / Kawaoka, Yoshihiro

    mBio

    2021  Volume 12, Issue 5, Page(s) e0198721

    Abstract: ... only the antibody reaction to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ... proinflammatory cytokine/chemokine expression was not upregulated in macrophages. SARS-CoV-2 infection ... of antibodies. Antibody-dependent enhancement (ADE) of infection is one of the biggest concerns in terms of not ...

    Abstract The coronavirus disease 2019 (COVID-19) pandemic has raised concerns about the detrimental effects of antibodies. Antibody-dependent enhancement (ADE) of infection is one of the biggest concerns in terms of not only the antibody reaction to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon reinfection with the virus but also the reaction to COVID-19 vaccines. In this study, we evaluated ADE of infection by using COVID-19 convalescent-phase plasma and BHK cells expressing human Fcγ receptors (FcγRs). We found that FcγRIIA and FcγRIIIA mediated modest ADE of infection against SARS-CoV-2. Although ADE of infection was observed in monocyte-derived macrophages infected with SARS-CoV-2, including its variants, proinflammatory cytokine/chemokine expression was not upregulated in macrophages. SARS-CoV-2 infection thus produces antibodies that elicit ADE of infection, but these antibodies do not contribute to excess cytokine production by macrophages.
    MeSH term(s) Animals ; Antibody-Dependent Enhancement/physiology ; Cell Line ; Cricetinae ; Cytokines/metabolism ; Humans ; Macrophages/metabolism ; Real-Time Polymerase Chain Reaction ; Receptors, IgG/genetics ; Receptors, IgG/metabolism ; SARS-CoV-2/pathogenicity
    Chemical Substances Cytokines ; FCGR3A protein, human ; Fc gamma receptor IIA ; Receptors, IgG
    Language English
    Publishing date 2021-09-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mBio.01987-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: No evidence for human monocyte-derived macrophage infection and antibody-mediated enhancement of SARS-CoV-2 infection

    Garcia-Nicolas, Obdulio / V'kovski, Philip / Zettl, Ferdinand / Zimmer, Gert / Thiel, Volker / Summerfield, Artur

    bioRxiv

    Abstract: Vaccines are essential to control the spread of severe acute respiratory syndrome coronavirus-2 ... cytokines in these cells, in sharp contrast to Middle East respiratory syndrome (MERS) coronavirus and ... enhancement of SARS-CoV-2 infection nor innate immune response in human macrophages. These results support ...

    Abstract Vaccines are essential to control the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and to protect the vulnerable population. However, one safety concern of vaccination is the possible development of antibody-dependent enhancement (ADE) of SARS-CoV-2 infection. The potential infection of Fc receptor bearing cells such as macrophages, would support continued virus replication and inflammatory responses, and thereby potentially worsen the clinical outcome of COVID-19. Here we demonstrate that SARS-CoV-2 and SARS-CoV-1 neither infect human monocyte-derived macrophages nor induce inflammatory cytokines in these cells, in sharp contrast to Middle East respiratory syndrome (MERS) coronavirus and the common cold human coronavirus 229E. Furthermore, serum from convalescent COVID-19 patients neither induced enhancement of SARS-CoV-2 infection nor innate immune response in human macrophages. These results support the view that ADE may not be involved in the immunopathological processes associated with COVID-19, however, more studies are necessary to understand the potential contribution of antibodies-virus complexes with other cells expressing FcR receptors.
    Keywords covid19
    Language English
    Publishing date 2020-12-23
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2020.12.22.423940
    Database COVID19

    Kategorien

  7. Article: Antibody-Dependent Enhancement of SARS-CoV-2 Infection of Human Immune Cells: In Vitro Assessment Provides Insight in COVID-19 Pathogenesis

    Shen, Xu-Rui / Li, Qian / Li, Hui-Ling / Wang, Xi / Wang, Qi / Zheng, Xiao-Shuang / Geng, Rong / Zhang, Yu-Lan / Li, Bei / Jiang, Ren-Di / Liu, Mei-Qin / Zhu, Yan / Zhang, Wei / Yang, Xing-Lou / Peng, Ke / Zhou, Peng

    Viruses. 2021 Dec. 11, v. 13, no. 12

    2021  

    Abstract: ... immune responses in immune cells. Our data revealed that SARS-CoV-2 infection of primary B cells, macrophages and ... COVID-19 through antibody-dependent enhancement (ADE) is still not fully understood. Here, we conducted ... patients. We also determined the factors associated with ADE, and found which showed a time-dependent ...

    Abstract Patients with COVID-19 generally raise antibodies against SARS-CoV-2 following infection, and the antibody level is positively correlated to the severity of disease. Whether the viral antibodies exacerbate COVID-19 through antibody-dependent enhancement (ADE) is still not fully understood. Here, we conducted in vitro assessment of whether convalescent serum enhanced SARS-CoV-2 infection or induced excessive immune responses in immune cells. Our data revealed that SARS-CoV-2 infection of primary B cells, macrophages and monocytes, which express variable levels of FcγR, could be enhanced by convalescent serum from COVID-19 patients. We also determined the factors associated with ADE, and found which showed a time-dependent but not viral-dose dependent manner. Furthermore, the ADE effect is not associated with the neutralizing titer or RBD antibody level when testing serum samples collected from different patients. However, it is higher in a medium level than low or high dilutions in a given sample that showed ADE effect, which is similar to dengue. Finally, we demonstrated more viral genes or dysregulated host immune gene expression under ADE conditions compared to the no-serum infection group. Collectively, our study provides insight into the understanding of an association of high viral antibody titer and severe lung pathology in severe patients with COVID-19.
    Keywords COVID-19 infection ; Severe acute respiratory syndrome coronavirus 2 ; blood serum ; dengue ; gene expression ; humans ; lungs ; macrophages ; monocytes ; pathogenesis ; viral antibodies
    Language English
    Dates of publication 2021-1211
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2516098-9
    ISSN 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v13122483
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article: Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus

    Yip, Ming Shum / Leung, Nancy Hiu Lan / Cheung, Chung Yan / Li, Ping Hung / Lee, Horace Hok Yeung / Daëron, Marc / Peiris, Joseph Sriyal Malik / Bruzzone, Roberto / Jaume, Martial

    Virology journal

    Volume v. 11,, Issue no. 1

    Abstract: ... and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome ... in human macrophages. METHODS: We have used primary human immune cells to evaluate their susceptibility ... BACKGROUND: Public health risks associated to infection by human coronaviruses remain considerable ...

    Abstract BACKGROUND: Public health risks associated to infection by human coronaviruses remain considerable and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome coronavirus (SARS-CoV). We have previously reported that antibodies elicited by a SARS-CoV vaccine candidate based on recombinant, full-length SARS-CoV Spike-protein trimers, trigger infection of immune cell lines. These observations prompted us to investigate the molecular mechanisms and responses to antibody-mediated infection in human macrophages. METHODS: We have used primary human immune cells to evaluate their susceptibility to infection by SARS-CoV in the presence of anti-Spike antibodies. Fluorescence microscopy and real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) were utilized to assess occurrence and consequences of infection. To gain insight into the underlying molecular mechanism, we performed mutational analysis with a series of truncated and chimeric constructs of fragment crystallizable γ receptors (FcγR), which bind antibody-coated pathogens. RESULTS: We show here that anti-Spike immune serum increased infection of human monocyte-derived macrophages by replication-competent SARS-CoV as well as Spike-pseudotyped lentiviral particles (SARS-CoVpp). Macrophages infected with SARS-CoV, however, did not support productive replication of the virus. Purified anti-viral IgGs, but not other soluble factor(s) from heat-inactivated mouse immune serum, were sufficient to enhance infection. Antibody-mediated infection was dependent on signaling-competent members of the human FcγRII family, which were shown to confer susceptibility to otherwise naïve ST486 cells, as binding of immune complexes to cell surface FcγRII was necessary but not sufficient to trigger antibody-dependent enhancement (ADE) of infection. Furthermore, only FcγRII with intact cytoplasmic signaling domains were competent to sustain ADE of SARS-CoVpp infection, thus providing additional information on the role of downstream signaling by FcγRII. CONCLUSIONS: These results demonstrate that human macrophages can be infected by SARS-CoV as a result of IgG-mediated ADE and indicate that this infection route requires signaling pathways activated downstream of binding to FcγRII receptors.
    Keywords antigen-antibody complex ; vaccines ; antibodies ; immunoglobulin G ; receptors ; humans ; signal transduction ; pathogens ; antiserum ; vaccination ; cell lines ; chimerism ; reverse transcriptase polymerase chain reaction ; risk ; mice ; virus replication ; fluorescence microscopy ; human diseases ; Severe acute respiratory syndrome coronavirus ; macrophages ; particles ; public health
    Language English
    Document type Article
    ISSN 1743-422X
    Database AGRIS - International Information System for the Agricultural Sciences and Technology

    More links

    Kategorien

To top